Cargando…

1525. Evaluation of Clinical Outcomes With Fosfomycin for E. coli and Non-E. coli Enterobacteriaceae Urinary Tract Infections

BACKGROUND: Fosfomycin is a broad-spectrum oral antibiotic increasingly used for the treatment of uncomplicated and complicated urinary tract infections (UTIs). The Clinical and Laboratory Standards Institute (CLSI) does not support fosfomycin susceptibility testing on urinary isolates outside of En...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Tiffany, Glaser, Laurel, Alby, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254295/ http://dx.doi.org/10.1093/ofid/ofy210.1354

Ejemplares similares

2819. Clinical Outcomes of Fosfomycin Treatment in E. coli vs. Non-E. coli Enterobacterales Urinary Tract Infection
por: Traugott, Kristi, et al.
Publicado: (2023)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

2261. Oral Fosfomycin for Treatment of Urinary Tract Infections Due to Extended-Spectrum β-Lactamase and Carbapenem-Resistant Enterobacteriaceae
por: Hefler, Jade L, et al.
Publicado: (2019)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

1689. Oral Beta-lactam Step Down in Bacteremic E. coli Urinary Tract Infections
por: Saad, Stephan, et al.
Publicado: (2020)

Bacillus Coli Infections of the Urinary Tract
Publicado: (1912)

Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012
por: Keepers, Tiffany R., et al.
Publicado: (2017)

High incidence of fosfomycin-resistant uropathogenic E. coli among children
por: Abdelraheem, Wedad M., et al.
Publicado: (2023)

Metabolic Adaptations of Uropathogenic E. coli in the Urinary Tract
por: Mann, Riti, et al.
Publicado: (2017)

2062. Evaluation of Susceptibility Testing Methods for Fosfomycin Against Enterobacteriaceae and Pseudomonas aeruginosa
por: De La Cadena, Elsa Piedad, et al.
Publicado: (2018)

1153. ESBL Producing E. coli Urinary Tract Infections in Children: Is Carbapenem Always Necessary?
por: del Carmen, Ruiz Cabrales Diva, et al.
Publicado: (2021)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

2180. Novel Method for Determining Rapid E.coli Antibiotic Susceptibility (AST) Results for Urinary Tract Infections
por: Kon, Shelley, et al.
Publicado: (2019)

Antibiotic resistance in children with E coli urinary tract infection
por: Russell, Grant
Publicado: (2016)

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)
por: ten Doesschate, Thijs, et al.
Publicado: (2018)

Molecular Epidemiology of Fosfomycin Resistant E. coli from a Pigeon Farm in China
por: Han, Lu, et al.
Publicado: (2021)

Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
por: Bielen, Luka, et al.
Publicado: (2019)

2422. Efficacy of Cefoxitin for the Treatment of Urinary Tract Infection (UTI) Due to ESBL-Producing E. coli and K. pneumoniae Isolates
por: Senard, Olivia, et al.
Publicado: (2018)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

1526. Oral Fosfomycin Use for Urinary Tract Infections and Its Clinical Impact on Hospital Stay
por: Mai, Christina, et al.
Publicado: (2018)

2396. Fosfomycin Resistance Among Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Connecticut, 2017
por: Snayd, Mary, et al.
Publicado: (2018)

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
por: Sojo-Dorado, Jesús, et al.
Publicado: (2022)

Oral beta-lactam step down in bacteremic E. coli urinary tract infections
por: Saad, Stephan, et al.
Publicado: (2020)

182. increasing Odds of Resistance for Subsequent Urinary e. Coli Isolates
por: Frisbie, Lauren, et al.
Publicado: (2020)

E. coli versus Non-E. coli Urinary Tract Infections in Children: A Study from a Large Tertiary Care Center in Saudi Arabia
por: Al Nafeesah, Abdullah, et al.
Publicado: (2022)

Lactose vs Non-Lactose Fermenting E. coli: Epidemiology, Clinical Outcomes, and Resistance
por: Yaratha, Gokul, et al.
Publicado: (2017)

Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
por: Alrowais, Hind, et al.
Publicado: (2015)

Characterization of E. coli Phylogroups Causing Catheter-Associated Urinary Tract Infection
por: El-Mahdy, Rasha, et al.
Publicado: (2021)

Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections
por: Amladi, Anushree Ulhas, et al.
Publicado: (2019)

1518. Assessment of Antibiotic Prescribing in the Outpatient Setting for Uncomplicated Urinary Tract Infection in Pediatrics (UTIP Trial) with a Review of Local E. coli Susceptibilities
por: Lee, Philip, et al.
Publicado: (2018)

2273. Outcomes of Trimethoprim/Sulfamethoxazole as Definitive Therapy for Urinary Tract Infections with Multi-Drug-Resistant Enterobacteriaceae
por: Adhi, Fatima, et al.
Publicado: (2019)

Oral and intravenous fosfomycin in complicated urinary tract infections
por: López-Montesinos, Inmaculada, et al.
Publicado: (2019)

1700. What Is Specific With Bacterial Escherichia Coli Urinary Tract Infection
por: Hammami, Fatma, et al.
Publicado: (2020)

1417. Fosfomycin Use in the Treatment of Complicated Urinary Tract Infections at a Veterans Affairs Medical Center
por: Lee, Ryan, et al.
Publicado: (2021)

Detection of ESBL in E.coli and K. pneumoniae isolated from urinary tract infection
por: Metri, B. C., et al.
Publicado: (2012)

Disseminated E. coli urinary tract infection resulting in septic arthritis of the glenohumeral joint
por: James, Rhodri, et al.
Publicado: (2023)

Inhibition of COX-2 signaling favors E. coli during urinary tract infection
por: Mohanty, Soumitra, et al.
Publicado: (2023)

2420. A Real-World Perspective on the Efficacy of Fosfomycin for Treatment of Multidrug-Resistant Pathogens Causing Urinary Tract Infections
por: Babiker, Ahmed, et al.
Publicado: (2018)

Effect of Glycerol on Fosfomycin Activity against Escherichia coli
por: Ortiz-Padilla, Miriam, et al.
Publicado: (2022)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tkfqe1tfbhpkqkhb31gp3a0ti6